Transethosomes: Rising Technology for Enhancing Transdermal Delivery of Drugs

Authors

  • Mamta Kadawla Principal, Department of Pharma Chemistry, D. K. Pharma College, Village – Dhani, Dist. Rewari 122001, Haryana, India
  • Lakshita Rao Assistant Professor, Department of Pharmaceutics, D. K. Pharma College, Village – Dhani, Dist. Rewari 122001, Haryana, India
  • Ritik Yadav Student, Department of Pharmacy, D. K. Pharma College, Village – Dhani, Dist. Rewari 122001, Haryana, India

Keywords:

Transethosomes, Transdermal, Skin, Drug Delivery, Preparation, Applications

Abstract

The skin has a total surface area of around 1.8 m2 and serves as the human body's interface with the outside world. The transdermal method of medication delivery has sparked a lot of interest in pharmaceutical research since it eliminates a lot of the issues that come with the oral route. Despite the fact that the skin, especially the stratum corneum, is a barrier to most medication absorption, it does offer a substantial (1.2 m2) and accessible surface area for drug diffusion. Several methods have recently been explored to improve bioactive delivery through transdermal distribution. Iontophoresis, electrophoresis, sonophoresis, chemical permeation enhancers, magnetophoresis, microneedles, and vesicular systems are some of the most common examples (liposomes, niosomes, elastic liposomes such as ethosomes, transfersomes and transethosomes). Transethosomes, which include both lipophilic and hydrophilic areas and may accept medicinal molecules with a broad range of solubility, seem to be the most promising of the bunch. Transethosomes may bend and pass through a constriction 5 to 10 times smaller than their own diameter. Because of the great deformability, intact vesicles may be penetrated more easily. Analgesics, anesthetics, corticosteroids, sex hormones, anticancer medicines, insulin, and other medications may all be delivered transdermally using these vesicles.

References

Mishra KK, Kaur CD, Verma S, Sahu AK, Dash DK, Kashyap P, Mishra SP. Transethosomes and nanoethosomes: Recent approach on transdermal drug delivery system. Nanomedicine. 2019;2:33-54.

Jondhalekar TM, Aher SS, Saudagar RB. Transethosome: Novel vesicular carrier for enhanced transdermal drug delivery system. Res J Pharm Technol. 2017;10(6):1816-9.

Bajaj KJ, Parab BS, Shidhaye SS. Nano-transethosomes: A Novel Tool for Drug Delivery through Skin. Indian J Pharm Edu Res. 2021;55(1):S1-S10.

Shaji J, Bajaj R. Transethosomes: A new prospect for enhanced transdermal delivery. Int J Pharm Sci Res. 2018;9(7):2681-5.

Sravani A, Shyamala SJ. An Updated Review on Transethosomes. World J Pharm Res. 2019;8(13):629-37.

Kumar L, Verma S, Singh K, Prasad D, Jain A. Ethanol based vesicular carriers in transdermal drug delivery: Nanoethosomes and transethosomes in focus. NanoWorld J 2016;2(3):41-51.

Hongwei Lin, et al. Increased skin permeation efficiency of imperatorin via charged ultradeformable lipid vesicles for transdermal delivery. Int J Nanomedicine. 2018 Feb 8;13:831-842.

Rencai Chen, et al. Ultradeformable Liposomes: a Novel Vesicular Carrier For Enhanced Transdermal Delivery of Procyanidins: Effect of Surfactants on the Formation, Stability, and Transdermal Delivery. AAPS PharmSciTech. 2017 Jul;18(5):1823-1832.

Jia-You Fang, et al. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm. 2006 Mar 9;310(1-2):131-8.

J-Y Fang, et al. Transdermal delivery of tea catechins by electrically assisted methods. Skin Pharmacol Physiol. 2006;19(1):28-37.

Downloads

Published

2022-01-13

Issue

Vol. 8 No. 3 (2021)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.